A Angelov

509 total citations
15 papers, 46 citations indexed

About

A Angelov is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, A Angelov has authored 15 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in A Angelov's work include Lipoproteins and Cardiovascular Health (2 papers), Peptidase Inhibition and Analysis (2 papers) and Vitamin K Research Studies (2 papers). A Angelov is often cited by papers focused on Lipoproteins and Cardiovascular Health (2 papers), Peptidase Inhibition and Analysis (2 papers) and Vitamin K Research Studies (2 papers). A Angelov collaborates with scholars based in Bulgaria and United States. A Angelov's co-authors include S Slavcheva, Bistra Galunska, Yoto Yotov, Trifon Chervenkov, Daniela Gerova and Аntoniya Kisheva and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and European Journal of Preventive Cardiology.

In The Last Decade

A Angelov

12 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Angelov Bulgaria 4 20 12 10 8 6 15 46
Esra Akyüz Özkan Türkiye 6 14 0.7× 12 1.0× 11 1.1× 8 1.0× 6 1.0× 21 65
Violet Habwe United States 3 17 0.8× 26 2.2× 7 0.7× 7 0.9× 5 0.8× 3 97
Sıbel Ocak Serın Türkiye 5 5 0.3× 11 0.9× 9 0.9× 8 1.0× 5 0.8× 18 62
Basil Paulus United States 3 19 0.9× 6 0.5× 8 0.8× 4 0.5× 3 0.5× 4 30
Oyintayo Ajiboye United States 5 11 0.6× 13 1.1× 3 0.3× 8 1.0× 4 0.7× 13 56
Sébastien Robinet Belgium 4 31 1.6× 10 0.8× 9 0.9× 2 0.3× 3 0.5× 7 52
Marios Ioannides Cyprus 5 30 1.5× 15 1.3× 22 2.2× 7 0.9× 11 71
Faris Zvizdić Bosnia and Herzegovina 5 30 1.5× 6 0.5× 10 1.0× 3 0.4× 3 0.5× 9 62
S. Kostić Serbia 5 17 0.8× 9 0.8× 3 0.3× 10 1.3× 3 0.5× 20 61
Eduardo Capuano Italy 4 8 0.4× 27 2.3× 7 0.7× 7 0.9× 2 0.3× 7 60

Countries citing papers authored by A Angelov

Since Specialization
Citations

This map shows the geographic impact of A Angelov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Angelov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Angelov more than expected).

Fields of papers citing papers by A Angelov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Angelov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Angelov. The network helps show where A Angelov may publish in the future.

Co-authorship network of co-authors of A Angelov

This figure shows the co-authorship network connecting the top 25 collaborators of A Angelov. A scholar is included among the top collaborators of A Angelov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Angelov. A Angelov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Galunska, Bistra, et al.. (2024). Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers. International Journal of Molecular Sciences. 25(6). 3517–3517. 4 indexed citations
2.
Slavcheva, S & A Angelov. (2023). HER2-Targeted Therapy—From Pathophysiology to Clinical Manifestation: A Narrative Review. Journal of Cardiovascular Development and Disease. 10(12). 489–489. 5 indexed citations
3.
Angelov, A, et al.. (2022). Sexual dysfunction in women with increased cardiovascular risk. European Journal of Preventive Cardiology. 29(Supplement_1). 2 indexed citations
5.
Yotov, Yoto, et al.. (2021). ASYMPTOMATIC HYPERURICEMIA AS A POTENTIAL METABOLIC RISK FACTOR FOR CORONARY ARTERY CALCIFICATION IN PATIENTS WITH ATRIAL FIBRILLATION OR HEART FAILURE. Journal of IMAB - Annual Proceeding (Scientific Papers). 27(1). 3634–3642. 1 indexed citations
6.
Kisheva, Аntoniya, et al.. (2021). Galectin-3 in patients with atrial fibrillation and restored sinus rhythm. SHILAP Revista de lepidopterología. 63(3). 329–336. 2 indexed citations
7.
Kisheva, Аntoniya, et al.. (2011). Upstream therapy in atrial fibrillation. 17(3-4). 3–3.
8.
Angelov, A, et al.. (1990). Disseminated intravascular coagulation in fowls after experimentally induced acute salmonellosis.. 88(2). 28–31. 1 indexed citations
9.
Angelov, A. (1989). [Intravascular coagulation in amniotic fluid embolism].. PubMed. 28(5). 24–9. 3 indexed citations
10.
Angelov, A, et al.. (1984). [Thrombotic complications originating in the lung in chronic respiratory insufficiency].. PubMed. 162(3). 256–61. 1 indexed citations
11.
Angelov, A, et al.. (1984). Endocardial Fibroelastosis. Pathology - Research and Practice. 178(4). 384–388. 16 indexed citations
12.
Angelov, A, et al.. (1980). [The single daily dose of gentamicin in the treatment of urinary tract infections (author's transl)].. PubMed. 122(6). 212–4. 5 indexed citations
13.
Angelov, A, et al.. (1979). [Frequency, etiological factors and the morphological characteristics of myocardial infarct in youth].. PubMed. 18(6). 55–62.
14.
Angelov, A, et al.. (1973). [The treatment of pancreatic pseudocysts].. PubMed. 26(1). 56–61. 1 indexed citations
15.
Angelov, A. (1962). [Malacoplakia of the urinary tract].. PubMed. 55. 371–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026